216B.204 Duties of cabinet -- Eligibility for certification.
419 words·~2 min read·
/ky/chapter-216b/216b-204A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
(1)The cabinet, shall, at a minimum:
(a)Require completion of the certification process for pharmacies,
manufacturers, distributors, and abortion facilities;
(b)Notify certified pharmacies, manufacturers, distributors, and abortion
facilities which physicians are registered as nonsurgical abortion
providers with the cabinet;
(c)Prohibit intentionally, knowingly, or recklessly shipping abortion-inducing
drugs to physicians who become unregistered;
(d)Audit newly certified pharmacies, manufacturers, and distributors within
ninety
(90)calendar days after certification and annually thereafter, to
ensure that all processes and procedures are in place and functioning to
support the requirements of the Abortion-Inducing Drug Certification
Program;
(e)Suspend immediately a pharmacist's, manufacturer's, or distributor's
certification if found to be noncompliant until full compliance is
demonstrated;
(f)Enforce compliance and develop a compliance reporting system;
(g)Prohibit pharmacies from intentionally, knowingly, or recklessly
dispensing or distributing abortion-inducing drugs directly to a patient in
the Commonwealth; and
(h)Require manufacturers and distributors of abortion-inducing drugs to
intentionally and knowingly distribute only to certified pharmacies and
in-person dispensing clinics, medical offices, and hospitals that are in
compliance with the United States Federal Drug Administration's outlined
Mifepristone Risk Evaluation and Mitigation Strategy in effect on April 14,
2022.
(2)To be eligible for certification, pharmacies, manufacturers, and distributors of
abortion-inducing drugs shall:
(a)Have either obtained a Kentucky license as a distributor, or a Kentucky
permit as a pharmacy or manufacturer;
(b)Only distribute to or fulfill prescriptions requested by qualified physicians
who are registered as nonsurgical abortion providers with the cabinet;
(c)Abide by all applicable standards of the National Association of Boards of
Pharmacy;
(d)For online sales or orders, hold a current pharmacy or pharma domain
and abide by all required standards by the National Association of Boards
of Pharmacy to maintain the domain;
(e)Follow all other applicable state or federal laws related to the
dispensation, distribution, or delivery of legend drugs, including
abortion-inducing drugs; and
(f)Follow all acceptable processes and procedures to maintain a
dispensation, distribution, or delivery system that is secure, confidential,
and follows all processes and procedures, including those for storage,
handling, shipping, tracking packages, serial numbers, National Drug
Codes, lot numbers, expiration dates, proof of delivery, and controlled
returns of abortion-inducing drugs.
(3)To be eligible for certification, pharmacies shall:
(a)Be certified by the United States Food and Drug Administration to
dispense abortion-inducing drugs;
(b)Submit proof of certification by the abortion-inducing drug manufacturer
for the distribution of abortion-inducing drugs; and
(c)Only fulfill prescriptions that are accompanied by the required patient
consent form.